Drugs and convalescent plasma therapy for COVID-19: a survey of the interventional clinical studies in Italy after 1 year of pandemic | Trials | 2022 |
Drug repurposing for the treatment of COVID-19 | Journal of Pharmacological Sciences | 2022 |
Comparison of First and 21st Day anti SARS-CoV-2 anti-spike IgM and IgG Responses | Turkish Journal of Immunology | 2022 |
Following the Science to Generate Well-Being: Using the Highest-Quality Experimental Evidence to Design Interventions. | Frontiers in Psychology | 2021 |
Identification of novel TMPRSS2 inhibitors against SARS-CoV-2 infection: a structure-based virtual screening and molecular dynamics study. | Structural Chemistry | 2022 |
The Convergence of HPC, AI and Big Data in Rapid-Response to the COVID-19 Pandemic | Communications in Computer and Information Science | 2022 |
Knowledge, attitude, and perception of public about participation in COVID-19 clinical trials: a study from Egypt and Saudi Arabia. | Saudi Pharmaceutical Journal | 2022 |
Coronavirus Disease 2019: Clinics, Treatment, and Prevention | Frontiers in Microbiology | 2021 |
“Safety and efficacy of pharmacotherapy used for the management of COVID 19: A systematic review and meta-analysis of randomized control trials” | | |
First-described recently discovered non-toxic vegetal-derived furocoumarin preclinical efficacy against SARS-CoV-2: a promising antiviral herbal drug | | |
COVID-19: State of the Vaccination | Drugs and Therapy Perspectives | 2021 |
Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations | Journal of Medical Biochemistry | 2020 |
COVID-19 Treatment: The Race Against Time | Electronic Journal of General Medicine | 2020 |
Toward Preparing a Knowledge Base to Explore Potential Drugs and Biomedical Entities Related to COVID-19: Automated Computational Approach | JMIR Medical Informatics | 2020 |
Experience of creating and the first results of the prospective hospital registry of patients with suspected or confirmed coronavirus infection (COVID-19) and community-acquired pneumonia (TARGET-VIP) | Profilakticheskaya Meditsina | 2020 |
Analysis of COVID-19 clinical trials: A data-driven, ontology-based, and natural language processing approach | PLoS ONE | 2020 |
Risk assessment of drug-induced Long QT Syndrome for some COVID-19 repurposed drugs | | |
COVID-19 and hepatitis B infection | Antiviral Therapy | 2020 |
Does tetanus vaccination contribute to reduced severity of the COVID-19 infection? | Medical Hypotheses | 2021 |
COMPARISON OF THE SIDE EFFECTS OF THE VARIOUS COVID-19 VACCINES | | 2021 |
Normative framework of informed consent in clinical research in Germany, Poland, and Russia | BMC Medical Ethics | 2021 |
Research and Management of Rare Diseases in the COVID-19 Pandemic Era: Challenges and Countermeasures | Frontiers in Public Health | 2021 |
The usefulness of NEWS2 at day 7 of hospitalization in predicting COVID-19 evolution and as an early endpoint in therapeutic trials | Journal of Infection | 2021 |
Understanding COVID-19 Pandemic: Molecular Mechanisms and Potential Therapeutic Strategies. An Evidence-Based Review | Journal of Inflammation Research | 2021 |
Efficacy and safety of tocilizumab in the management of COVID-19: A systematic review and meta-analysis of observational studies | | |
Emergency Use Authorization for Remdesivir and Its Potential Implications | Therapeutic Innovation and Regulatory Science | 2021 |
A review: Epidemiology, pathogenesis and prospect in developing vaccines for novel Coronavirus (COVID-19) | Indian Journal of Tuberculosis | 2021 |
Pregnant Women in Trials of Covid-19: A Critical Time to Consider Ethical Frameworks of Inclusion in Clinical Trials | Ethics & Human Research | 2020 |
Contraception and reproductive planning during the COVID-19 pandemic | Expert Review of Clinical Pharmacology | 2020 |
Ten challenging questions about SARS-CoV-2 and COVID-19 | Expert Review of Respiratory Medicine | 2020 |
A Narrative Review of Emerging Therapeutics for COVID-19 | Mayo Clinic Proceedings Innovations, Quality & Outcomes | 2020 |
COVID-19: An overview of the current pharmacological interventions, vaccines, and clinical trials | Biochemical Pharmacology | 2020 |
Facilitating Both Evidence and Access: Improving FDA's Accelerated Approval and Expanded Access Pathways | Journal of Law, Medicine and Ethics | 2020 |
as a potential future drug molecule for COVID-19 | Future Drug Discovery | 2020 |
Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics | Life Sciences | 2020 |
COVID-2019 - A comprehensive pathology insight | Pathology Research and Practice | 2020 |